Bellerophon Therapeutics Inc
BLPH
Get informed when a big investor buys or sells
+ FollowMarket Cap$146.79K
Close$
Share Statistics
| Market cap | $146,791.00 |
|---|---|
| Enterprise Value | $-4,235,209.00 |
| Dividend Yield | $0.02 (-) |
| Earnings per Share | $-2.08 |
| Beta | 0.7 |
| Outstanding Shares | 12,232,648 |
Return
| Return on Equity | -313.46% |
|---|---|
| Return on Assets | -234.38% |
| Return on Invested Capital | -296.43% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.75 |
| Enterprise Value to EBIT | 0.38 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bellerophon Therapeutics Inc
CEO: Fabian Tenenbaum